REFERENCES
1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R.
Pre-eclampsia. Lancet 2010; 376 (9741): 631-44.
2. Duley L. The global impact of pre-eclampsia and eclampsia.Semin Perinatol 2009; 33 (3): 130-7.
3. Liu S, Joseph KS, Liston RM, et al. Incidence, risk factors, and
associated complications of eclampsia. Obstet Gynecol 2011;118 (5): 987-94.
4. ACOG Practice Bulletin No. 202: Gestational Hypertension and
Preeclampsia. Obstet Gynecol 2019; 133 (1): e1-e25.
5. Smith JM, Lowe RF, Fullerton J, Currie SM, Harris L, Felker-Kantor E.
An integrative review of the side effects related to the use of
magnesium sulfate for pre-eclampsia and eclampsia management. BMC
Pregnancy Childbirth 2013; 13 : 34.
6. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium
sulphate and other anticonvulsants for women with pre-eclampsia.Cochrane Database Syst Rev 2010; (11): CD000025.
7. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for
systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.Syst Rev 2015; 4 : 1.
8. Higgins JPT GS, Sally E, Cochrane Collaboration. Cochrane handbook
for systematic reviews of interventions. Chichester, England:
Wiley-Blackwell; 2011. .
9. Darngawn L, Jose R, Regi A, Bansal R, Jeyaseelan L. A shortened
postpartum magnesium sulfate prophylaxis regime in pre-eclamptic women
at low risk of eclampsia. Int J Gynaecol Obstet 2012;116 (3): 237-9.
10. Ehrenberg HM, Mercer BM. Abbreviated postpartum magnesium sulfate
therapy for women with mild preeclampsia: a randomized controlled trial.Obstet Gynecol 2006; 108 (4): 833-8.
11. Fontenot MT, Lewis DF, Frederick JB, et al. A prospective randomized
trial of magnesium sulfate in severe preeclampsia: use of diuresis as a
clinical parameter to determine the duration of postpartum therapy.Am J Obstet Gynecol 2005; 192 (6): 1788-93; discussion
93-4.
12. Kashanian M, Koohpayehzadeh J, Sheikhansari N, Bararpour F, Sahraian
G, Asadolla S. A comparison between the two methods of magnesium sulfate
administration for duration of 12 versus 24 h after delivery in patients
with severe preeclampsia. J Matern Fetal Neonatal Med 2016;29 (14): 2282-7.
13. Maia SB, Katz L, Neto CN, Caiado BV, Azevedo AP, Amorim MM.
Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium
sulfate therapy in severe pre-eclampsia. Int J Gynaecol Obstet2014; 126 (3): 260-4.
14. Rimal SP, Rijal P, Bhatt R, Thapa K. Loading Dose only versus
Standard Dose Magnesium Sulfate Seizure Prophylaxis in Severe
Pre-eclamptic Women. JNMA J Nepal Med Assoc 2017;56 (208): 388-94.
15. Vigil-De Gracia P, Ramirez R, Duran Y, Quintero A. Magnesium sulfate
for 6 vs 24 hours post delivery in patients who received magnesium
sulfate for less than 8 hours before birth: a randomized clinical trial.BMC Pregnancy Childbirth 2017; 17 (1): 241.
16. Vigil-DeGracia P, Ludmir J, Ng J, et al. Is there benefit to
continue magnesium sulphate postpartum in women receiving magnesium
sulphate before delivery? A randomised controlled study. BJOG2018; 125 (10): 1304-11.
17. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia,
and their babies, benefit from magnesium sulphate? The Magpie Trial: a
randomised placebo-controlled trial. Lancet 2002;359 (9321): 1877-90.
18. Anjum SG, Nidhi & Alvi, Yasir & R. Gade, Pramod & Bano, Imam.
(2017). Maternal Outcome with Discontinuation of Magnesium Sulfate
immediately Postpartum in Severe Preeclampsia. 9. 84-7.
10.5005/jp-journals-10006-1464. .
19. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons
learned from recent trials. Am J Obstet Gynecol 2004;190 (6): 1520-6.